A physician by training who now directs cutting-edge scientific research in oncology.
Nina Bhardwaj is the director of immunotherapy and medical director of the Vaccine and Cell Therapy Laboratory at the Icahn School of Medicine at Mount Sinai and co-director of the Cancer Immunology Program at the Tisch Cancer Institute. Her focus is on translating basic science into clinically relevant patient trials, with a particular focus on dendritic cell-based immunotherapies. She is also a member of the Cancer Research Institute’s scientific advisory council and clinical leadership committee. She is a senior editor for Cancer Immunology Research and Frontiers in Immunology. Nina has served on numerous NIH study sections and advisory councils and was formerly chair of the Cancer Immunology Steering Committee of the American Association for Cancer Research. She has secured multiple federal and foundation grants and has authored more than 200 publications. Nina was named one of Scientific American’s Top 50 Researchers in 2004. In recognition of her accomplishments, she also received the 2015 Frederick W. Alt Award for New Discoveries in Immunology. Nina earned her Ph.D. from NYU’s Medical School, where she went on to work as a professor of medicine, pathology and dermatology as well as was the director of the tumor vaccine program.